About KKR
KKR is one of the largest global investment firms, headquartered in New York and active across private equity, growth, infrastructure, real estate, and credit. Within healthcare, KKR invests aggressively in Care Delivery and Pharma/Therapeutics, often deploying multi-billion-dollar tranches into platform-defining transactions. AI is not a dedicated thesis, but KKR has invested in tech-enabled health platforms. Specific healthcare AUM is not detailed in the source data, though the firm is among the largest globally.
Check sizes start at $25M+ and routinely exceed several hundred million dollars in a single transaction. KKR operates globally, with active deal flow in North America, Europe, and Asia. Specific healthcare portfolio companies are not listed in the source data. Diligence is institutional-grade and lengthy, with deep operational and financial scrutiny.
For early-stage physician AI founders, KKR is not relevant. The firm becomes a fit only when a company has reached genuinely significant scale – hundreds of millions in revenue, mature unit economics, and credible category leadership. The right profile is the CEO of an established healthcare platform considering a major buyout, recap, or take-private. Founders earlier in the journey should ignore KKR and focus on stage-appropriate investors.
Founder reviews
Healthcare AI tools backed by KKR
Tools made by companies in KKR's portfolio that we cover in the directory.
Portfolio companies in our directory
Other portfolio companies
Companies in KKR's portfolio not currently in our directory.
Team
Pitch / review this investor
Have you raised from KKR? Founders only — share your honest experience (anonymous OK, moderated before publishing).